{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-047965","form_type":"8-K","ticker":"CPHI","cik":"0001106644","company_name":"CHINA PHARMA HOLDINGS, INC.","filed_at":"2024-05-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.305168+00:00","generated_at":"2026-06-01T07:19:41.926815+00:00","sec_items":["1.01","9.01"],"event_type":"debt","sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"China Pharma extends convertible note maturity to Aug. 2025; minimum monthly payment cut 75%","bullets":["Maturity date of $557,735 convertible note (Streeterville Capital) extended to August 19, 2025.","Extension fee equal to 2% of outstanding balance added to principal; balance post-fee is $557,735.","Minimum monthly redemption amount reduced from $150,000 to $37,182.33 per month.","Original note principal was $5,250,000 issued November 2021; prior amendment in April 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-047965","json":"https://secwatch.observer/filing/0001213900-24-047965.json","markdown":"https://secwatch.observer/filing/0001213900-24-047965.md","text":"https://secwatch.observer/filing/0001213900-24-047965.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1106644/000121390024047965/0001213900-24-047965-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1106644/000121390024047965/ea0207083-8k_china.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T07:19:41.926815+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}